Mirae Asset Global ETFs Holdings
KROS icon

Mirae Asset Global ETFs Holdings’s Keros Therapeutics KROS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Sell
13,891
-1,426
-9% -$22K ﹤0.01% 2482
2025
Q4 		$312K Sell
15,317
-2,824
-16% -$49.5K ﹤0.01% 2137
2025
Q3 		$287K Buy
+18,141
New +$268K ﹤0.01% 2130
2025
Q2 		– Sell
-22,166
Closed -$227K – 3131
2025
Q1 		$227K Buy
22,166
+2,982
+16% +$34.6K ﹤0.01% 2260
2024
Q4 		$303K Buy
19,184
+1,386
+8% +$72K ﹤0.01% 2163
2024
Q3 		$1.03M Buy
17,798
+2,615
+17% +$129K ﹤0.01% 1524
2024
Q2 		$692K Buy
+15,183
New +$816K ﹤0.01% 1660

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return